The post-Brexit UK is continuing to make its way outside the EU with a view to ensuring it is an important market for attracting investment, launching innovative new medicines and conducting clinical research. The Pink Sheet takes a look at how the country is managing to develop its regulatory and market access environment in an effort to achieve those aims.
In 2022, the importance of international collaborations and regulatory reliance was cemented as a way of securing quicker marketing authorizations....








